Clinical study and follow-up of 100 patients with the antiphospholipid syndrome (Q33331100)

25 July 2017

title

Clinical study and follow-up of 100 patients with the antiphospholipid syndrome (English)

1 reference

antiphospholipid syndrome

25 July 2017

0 references

1 reference

inferred from title

author

Ricard Cervera i Segura

3

object named as

Cervera R

1 reference

25 July 2017

6

Espinosa G

1 reference

25 July 2017

2

Font J

1 reference

25 July 2017

11

Ingelmo M

1 reference

Joan Carles Reverter Calatayud

25 July 2017

1 reference

ORCID Public Data File 2021

author name string

Muñoz-Rodriguez FJ

1

1 reference

25 July 2017

Reverter JC

4

1 reference

25 July 2017

Tàssies D

5

1 reference

25 July 2017

López-Soto A

7

1 reference

25 July 2017

Carmona F

8

1 reference

25 July 2017

Balasch J

9

1 reference

25 July 2017

Ordinas A

10

1 reference

25 July 2017

publication date

1 December 1999

1 reference

Seminars in Arthritis and Rheumatism

25 July 2017

published in

1 reference

25 July 2017

volume

29

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

182-190

1 reference

Antiphospholipid antibodies and antiphospholipid syndrome.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Immunology of the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Serological markers of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Clinicopathologic correlations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Clinical manifestations and management of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Monitoring warfarin therapy in patients with lupus anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Antiphospholipid antibodies and fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Obstetric outcome in antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980029-8

7 January 2021

10.1016/S0049-0172(99)80029-8

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/26pnvjk3pjgttltay2c3radxcy

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_26pnvjk3pjgttltay2c3radxcy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/26pnvjk3pjgttltay2c3radxcy

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/26pnvjk3pjgttltay2c3radxcy

1 reference

30 July 2022